- Condition: Polycystic Ovary Syndrome
Interventions: Drug: Zoely; Drug: Yasmin
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified May 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Metformin; Drug: Yasmin;; Drug: Metformin plus Yasmin
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Completed - verified April 2012 - Condition: Metrorrhagia
Interventions: Drug: barrier methods; Drug: barrier methods
Sponsors: Eurofarma Laboratorios S.A.; Eurofarma Laboratorios S.A.
Not yet recruiting - verified March 2012 - Conditions: Glioblastoma; Small Cell Glioblastoma; Giant Cell Glioblastoma; Gliosarcoma; Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF; Drug: Temozolomide; Drug: KLH
Sponsors: Celldex Therapeutics; Celldex Therapeutics
Recruiting - verified May 2012 - Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary SyndromeConditions: Polycystic Ovary Syndrome; Endothelial Dysfunction
Intervention: Drug: Metformin, Ethinylestradiol 30µg-Drospirenone
Sponsors: Iuliu Hatieganu University of Medicine and Pharmacy; Iuliu Hatieganu University of Medicine and Pharmacy
Active, not recruiting - verified October 2011 - Condition: Breast Cancer
Interventions: Behavioral: Motivational Interviewing; Behavioral: Counseling
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Department of Defense
Recruiting - verified January 2012 - Conditions: Perennial Rhinitis; Seasonal Rhinitis
Intervention:
Sponsors: Nycomed Mexico; Nycomed Mexico
Not yet recruiting - verified March 2011
 |
Yasmin 28 Clinical Trials and Research Studies |
